← Back to CTSO

Cytosorbents Corporation - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 13/05/2026Sep 2025Filed 13/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 13/05/2026Sep 2024Filed 13/11/2025Jun 2024Filed 07/08/2025Mar 2024Filed 14/05/2025
$9.6$8.9$9.5$9.6$8.7$8.6$8.8$9
−$4.4−$5.1−$3.2$1.9−$1.5−$2.8−$4.3−$6.1
−$0.07−$0.08−$0.05$0.03−$0.02−$0.05−$0.08−$0.11
6363636761545454

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.